LabCorp announced that John Ratliff is departing the company to pursue another opportunity. Dr. Brian Caveney has been named executive vice president and president of Diagnostics. Mark Schroeder has been named executive vice president and president of Diagnostics laboratory operations and global supply chain. These new roles are effective immediately.
“We are grateful to John for his leadership of the Covance business, and we wish him well in his next endeavors,” said Adam H. Schechter, president and CEO of LabCorp. “The board and I are pleased that Brian and Mark, two highly respected and strong leaders, will combine their unique skill sets for the continued growth of our Diagnostics business.”
Schechter continued: “In his roles as chief medical officer and head of managed care, and with his background as a former practicing physician and managed care executive, Brian has a deep understanding of our customers at every level, from patients and physicians, to hospitals and health systems, to our managed care partners. Mark’s expertise in global supply chain — which is integral to our lab operations — and his commitment to operational excellence are unparalleled. Brian and Mark will work closely together to enable us to become even more focused on our customers and the front line while we continue to enhance our remarkable lab capabilities and processes.”
“Our mission to improve health and improve lives requires us to put customers at the center of all we do,” said Caveney. “I look forward to working with Mark to build on our 50-year history of unmatched scientific advances in laboratory medicine to serve our full range of customers.”
“As head of LabCorp’s supply chain and as an integral architect of our LaunchPad process improvement initiatives, I have had the privilege to work in areas that touch every aspect of our labs,” said Schroeder. “I look forward to using my in-depth experience of our labs and operations to collaborate with Brian as we bring Diagnostics to the next level of achievement.”
